Stay updated on Gantenerumab in Mild Alzheimer Disease Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.

Latest updates to the Gantenerumab in Mild Alzheimer Disease Clinical Trial page
- Check3 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The site revision label also changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check31 days agoChange DetectedThe page now displays a 403 Forbidden error screen with a minimal header and a Home link, replacing the full study record content that was previously visible. This indicates restricted access to the page.SummaryDifference18%

- Check38 days agoChange DetectedThe page's revision tag was updated from Revision: v3.6.6 to Revision: v3.7.0, indicating a new version of the page rather than a change to the study content.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision: v3.6.6 replaces the previous v3.6.5 as the page's revision label, indicating a software/UI update rather than changes to the study data.SummaryDifference0.0%

- Check73 days agoChange DetectedThe site revision label was updated from Revision: v3.6.4 to Revision: v3.6.5, indicating a newer version of the site software.SummaryDifference0.0%

Stay in the know with updates to Gantenerumab in Mild Alzheimer Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.